Iterative Therapeutics Inc.
Biotech · Private
Engineered monoclonal antibodies with novel Fc regions (HCH polymers) that enhance NK cell activation and ADCC for cancer treatment
- Grants
- $300K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 1 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Enhanced NK cell activation via Fc receptor ligand - cytokine combinations | $150,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Enhanced NK cell activation via Fc receptor ligand cytokine combinations | $150,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1757 | REACTIVE BIOSCIENCES INC | — | $43M |
| 1758 | Aerpio Therapeutics LLC | — | $45M |
| 1759 | SERINA THERAPEUTICS INC | — | $34M |
| 1760 | Iterative Therapeutics Inc. | — | — |
| 1761 | Rhodium Scientific, LLC | — | — |
| 1762 | Klogene Therapeutics, Inc. | — | — |
| 1763 | TellBio, Inc. | — | $11M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Polymeric Immunoglobulin Fusion Proteins That Target Low-affinity FCγ Receptorsapplication
- Fusion proteins and their related methodsapplication
- Fusion proteins and their related methodsapplication
- Nucleic acids related to fusion proteinsgranted
- Methods And Compositions Involving Polymeric Immunoglobulin Fusion Proteinsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.